Cp4 - Weighted Average Calculations for Populating Cost-Effectiveness Models: How Ignoring the Model’s Clinical Pathways Can Significantly Bias the Incremental Cost-Effectiveness Ratio (Icer)
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.030
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV